Results 221 to 230 of about 54,158 (261)

The Association between Hypoperfused Myocardium and Systolic Function in Patients With AMI Undergoing Complete Revascularization

Clinical Cardiology, Volume 49, Issue 8, August 2026.
Hypoperfused myocardium was detected in portions of acute myocardial infarction patients undergoing complete revascularization by hybrid positron emission tomography/magnetic resonance at 2 months. Patients with hypoperfused myocardium (Group A) had higher hs‐CRP and lower T2 values than those without (Group B). The reversal of myocardial perfusion was
Jin Si, Chong Zheng, Jinghao Sun, Keling Xiao, Yadong Cui, Bixiao Cui, Ming Yi, Lijie Sun, Haoyu Zhang, Shanshan Gu, Jie Lu, Jing Li   +11 more
wiley   +1 more source

Mean platelet volume as a translational biomarker for cardiovascular risk stratification with perspectives for medical education: a systematic review. [PDF]

Glob Cardiol Sci Pract
López-Muñoz DF, Velandia-Mosquera CC, Cruz-Becerra OE, Agudelo DA, Pineda-Arias E, Girón-Girón ML.   +5 more
europepmc   +1 more source

The Association Between Temperature Variability and Acute Coronary Syndrome Admissions: A Retrospective Study. [PDF]

Cureus
Caglar SO, Hira S.
europepmc   +1 more source

Sex-specific differences in the prognostic value of ischemic pre-hospital ECGs. [PDF]

Front Cardiovasc Med
Sams LE, Bachinger L, Maul M, Villegas Sierra LE, Woerndl M, Tauber J, Mourouzis K, Korovesis F, Klemm M, Freyer L, Massberg S, Rizas KD.   +11 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myocardial Bridging in a Man With Non–ST-Elevation Myocardial Infarction

Circulation, 2015
A 75-year-old man with hyperlipidemia was admitted with substernal chest tightness associated with an elevated cardiac-specific troponin. He had experienced symptoms of an upper respiratory tract infection with fever, cough, and decreased oral intake over the previous 2 weeks.
Brian A, Bergmark, Benjamin Z, Galper, Amil M, Shah, Deepak L, Bhatt   +3 more
openaire   +2 more sources

Management of non–ST-Segment Elevation Myocardial Infarction

Medical Clinics of North America, 2007
Non-ST-segment elevation myocardial infarction (NSTEMI) is a major cause of cardiovascular morbidity and mortality in the United States. It represents the highest risk category of non-ST-segment elevation acute coronary syndromes (NSTEACS), for which timely diagnosis and appropriate therapy are paramount to improve outcomes.
Stephen E, Van Horn, Calin V, Maniu
openaire   +2 more sources

Timing of angiography in non-ST elevation myocardial infarction

Heart, 2013
Acute chest pain remains one of the most difficult challenges for the clinician. Nowadays, chest pain and its related complaints account for up to 10% of the adult emergency admissions and around 25% of all hospital admissions.w1 Notably, the number of patients presenting with complaints of chest pain is rising.w2 In a typical population of patients ...
Riezebos, R.K., Verheugt, F.W.A.
openaire   +3 more sources

Revascularization Strategies for Non-ST-Elevation Myocardial Infarction

Current Cardiology Reports, 2019
Non-ST-elevation myocardial infarction (NSTEMI) is an urgent medical condition that requires prompt application of simultaneous pharmacologic and non-pharmacologic therapies. The variation in patient clinical characteristics coupled with the multitude of treatment modalities makes optimal and timely management challenging.
Bennet, George, Naoki, Misumida, Khaled M, Ziada   +2 more
openaire   +2 more sources

Bad medicine: non-ST elevation myocardial infarction

BMJ, 2013
No one ever got sued for doing too much. Accordingly, 60% of the UK patients prescribed statins are considered at low risk—that is, they do not need treatment.1 2 But doctors are treating cholesterol concentrations. No one is interested in the abstract concept of risk. It’s easier to do something than nothing. However, while a diagnosis may last only a
openaire   +2 more sources